Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients

R. Houston Thompson, Bradley C. Leibovich, Robert Jeffrey Karnes, Eric J. Bergstralh, Michael L. Blute

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: Surgical treatment of transplant recipients in whom prostate cancer subsequently develops has been reported only sporadically in the literature. We reviewed our experience with radical retropubic prostatectomy in patients with solid organ transplants. Materials and Methods: Using our prostatectomy registry we identified 17 patients who underwent radical retropubic prostatectomy between 1988 and 2005 following organ transplantation. Clinicopathological features and outcome data were reviewed. Results: Kidney, liver and heart transplants were performed before radical retropubic prostatectomy in 9, 7 and 3 patients, respectively. Median age at transplant and time of radical retropubic prostatectomy was 51 (range 37 to 65) and 59 years (range 45 to 70), respectively. Median prostate specific antigen was 5.8 (range 2.6 to 12.9) and all patients had clinically localized disease. Ten patients had a pathological Gleason score of 6 while the remaining had Gleason scores 7 or greater. No patient had positive lymph nodes and only 2 patients had pT3a or greater disease. Early complications included wound infection in 2 (12%) patients along with hematoma and myocardial infarction in 1 (6%) patient each. Late complications included incontinence (1 or more pads per day) in 2 patients while no patient had a hernia, bladder neck contracture, venous thrombosis or lymphocele. With a median followup of 4.9 years, biochemical recurrence developed in 1 patient and no patient had systemic progression or death due to prostate cancer. Conclusions: To our knowledge we report the largest experience with radical retropubic prostatectomy in transplant recipients. Our results suggest that radical retropubic prostatectomy is feasible for immunosuppressed patients, yet concern for infection and wound healing remain important. Healthy transplant recipients with an increased prostate specific antigen should undergo a prostate biopsy.

Original languageEnglish (US)
Pages (from-to)1349-1353
Number of pages5
JournalJournal of Urology
Volume179
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

Prostatectomy
Neoplasm Grading
Prostate-Specific Antigen
Transplant Recipients
Transplants
Prostatic Neoplasms
Lymphocele
Organ Transplantation
Contracture
Wound Infection
Hernia
Venous Thrombosis
Hematoma
Wound Healing
Registries
Prostate
Urinary Bladder
Lymph Nodes
Myocardial Infarction

Keywords

  • heart transplantation
  • kidney transplantation
  • liver transplantation
  • prostatectomy
  • prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Thompson, R. H., Leibovich, B. C., Karnes, R. J., Bergstralh, E. J., & Blute, M. L. (2008). Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients. Journal of Urology, 179(4), 1349-1353. https://doi.org/10.1016/j.juro.2007.11.054

Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients. / Thompson, R. Houston; Leibovich, Bradley C.; Karnes, Robert Jeffrey; Bergstralh, Eric J.; Blute, Michael L.

In: Journal of Urology, Vol. 179, No. 4, 04.2008, p. 1349-1353.

Research output: Contribution to journalArticle

Thompson, RH, Leibovich, BC, Karnes, RJ, Bergstralh, EJ & Blute, ML 2008, 'Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients', Journal of Urology, vol. 179, no. 4, pp. 1349-1353. https://doi.org/10.1016/j.juro.2007.11.054
Thompson, R. Houston ; Leibovich, Bradley C. ; Karnes, Robert Jeffrey ; Bergstralh, Eric J. ; Blute, Michael L. / Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients. In: Journal of Urology. 2008 ; Vol. 179, No. 4. pp. 1349-1353.
@article{d35114eaaee548508fa03f6e61104986,
title = "Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients",
abstract = "Purpose: Surgical treatment of transplant recipients in whom prostate cancer subsequently develops has been reported only sporadically in the literature. We reviewed our experience with radical retropubic prostatectomy in patients with solid organ transplants. Materials and Methods: Using our prostatectomy registry we identified 17 patients who underwent radical retropubic prostatectomy between 1988 and 2005 following organ transplantation. Clinicopathological features and outcome data were reviewed. Results: Kidney, liver and heart transplants were performed before radical retropubic prostatectomy in 9, 7 and 3 patients, respectively. Median age at transplant and time of radical retropubic prostatectomy was 51 (range 37 to 65) and 59 years (range 45 to 70), respectively. Median prostate specific antigen was 5.8 (range 2.6 to 12.9) and all patients had clinically localized disease. Ten patients had a pathological Gleason score of 6 while the remaining had Gleason scores 7 or greater. No patient had positive lymph nodes and only 2 patients had pT3a or greater disease. Early complications included wound infection in 2 (12{\%}) patients along with hematoma and myocardial infarction in 1 (6{\%}) patient each. Late complications included incontinence (1 or more pads per day) in 2 patients while no patient had a hernia, bladder neck contracture, venous thrombosis or lymphocele. With a median followup of 4.9 years, biochemical recurrence developed in 1 patient and no patient had systemic progression or death due to prostate cancer. Conclusions: To our knowledge we report the largest experience with radical retropubic prostatectomy in transplant recipients. Our results suggest that radical retropubic prostatectomy is feasible for immunosuppressed patients, yet concern for infection and wound healing remain important. Healthy transplant recipients with an increased prostate specific antigen should undergo a prostate biopsy.",
keywords = "heart transplantation, kidney transplantation, liver transplantation, prostatectomy, prostatic neoplasms",
author = "Thompson, {R. Houston} and Leibovich, {Bradley C.} and Karnes, {Robert Jeffrey} and Bergstralh, {Eric J.} and Blute, {Michael L.}",
year = "2008",
month = "4",
doi = "10.1016/j.juro.2007.11.054",
language = "English (US)",
volume = "179",
pages = "1349--1353",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients

AU - Thompson, R. Houston

AU - Leibovich, Bradley C.

AU - Karnes, Robert Jeffrey

AU - Bergstralh, Eric J.

AU - Blute, Michael L.

PY - 2008/4

Y1 - 2008/4

N2 - Purpose: Surgical treatment of transplant recipients in whom prostate cancer subsequently develops has been reported only sporadically in the literature. We reviewed our experience with radical retropubic prostatectomy in patients with solid organ transplants. Materials and Methods: Using our prostatectomy registry we identified 17 patients who underwent radical retropubic prostatectomy between 1988 and 2005 following organ transplantation. Clinicopathological features and outcome data were reviewed. Results: Kidney, liver and heart transplants were performed before radical retropubic prostatectomy in 9, 7 and 3 patients, respectively. Median age at transplant and time of radical retropubic prostatectomy was 51 (range 37 to 65) and 59 years (range 45 to 70), respectively. Median prostate specific antigen was 5.8 (range 2.6 to 12.9) and all patients had clinically localized disease. Ten patients had a pathological Gleason score of 6 while the remaining had Gleason scores 7 or greater. No patient had positive lymph nodes and only 2 patients had pT3a or greater disease. Early complications included wound infection in 2 (12%) patients along with hematoma and myocardial infarction in 1 (6%) patient each. Late complications included incontinence (1 or more pads per day) in 2 patients while no patient had a hernia, bladder neck contracture, venous thrombosis or lymphocele. With a median followup of 4.9 years, biochemical recurrence developed in 1 patient and no patient had systemic progression or death due to prostate cancer. Conclusions: To our knowledge we report the largest experience with radical retropubic prostatectomy in transplant recipients. Our results suggest that radical retropubic prostatectomy is feasible for immunosuppressed patients, yet concern for infection and wound healing remain important. Healthy transplant recipients with an increased prostate specific antigen should undergo a prostate biopsy.

AB - Purpose: Surgical treatment of transplant recipients in whom prostate cancer subsequently develops has been reported only sporadically in the literature. We reviewed our experience with radical retropubic prostatectomy in patients with solid organ transplants. Materials and Methods: Using our prostatectomy registry we identified 17 patients who underwent radical retropubic prostatectomy between 1988 and 2005 following organ transplantation. Clinicopathological features and outcome data were reviewed. Results: Kidney, liver and heart transplants were performed before radical retropubic prostatectomy in 9, 7 and 3 patients, respectively. Median age at transplant and time of radical retropubic prostatectomy was 51 (range 37 to 65) and 59 years (range 45 to 70), respectively. Median prostate specific antigen was 5.8 (range 2.6 to 12.9) and all patients had clinically localized disease. Ten patients had a pathological Gleason score of 6 while the remaining had Gleason scores 7 or greater. No patient had positive lymph nodes and only 2 patients had pT3a or greater disease. Early complications included wound infection in 2 (12%) patients along with hematoma and myocardial infarction in 1 (6%) patient each. Late complications included incontinence (1 or more pads per day) in 2 patients while no patient had a hernia, bladder neck contracture, venous thrombosis or lymphocele. With a median followup of 4.9 years, biochemical recurrence developed in 1 patient and no patient had systemic progression or death due to prostate cancer. Conclusions: To our knowledge we report the largest experience with radical retropubic prostatectomy in transplant recipients. Our results suggest that radical retropubic prostatectomy is feasible for immunosuppressed patients, yet concern for infection and wound healing remain important. Healthy transplant recipients with an increased prostate specific antigen should undergo a prostate biopsy.

KW - heart transplantation

KW - kidney transplantation

KW - liver transplantation

KW - prostatectomy

KW - prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=40849092398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849092398&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2007.11.054

DO - 10.1016/j.juro.2007.11.054

M3 - Article

C2 - 18289598

AN - SCOPUS:40849092398

VL - 179

SP - 1349

EP - 1353

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -